Less labor-intensive approaches, such as those based on the yeast two-hybrid system for cloning interacting partners (Chien et al., 1991) , cannot be used since growth factor-receptor binding depends on a large interacting surface between two essentially full-length and correctly folded proteins (de Vos et al., 1992) , the folding of which depends on correct disulfide pairing, which usually occurs efficiently only during secretion from mammalian cells. The yeast two-hybrid system takes advantage of interactions between short stretches of peptides that can occur within the reducing environment found within the yeast cell cytoplasm.
The expression cloning of cDNAs encoding membrane-bound (as opposed to secreted) ligands for orphan receptors has been far easier. Transfection of entire cDNA libraries into large numbers of cells can be used and still allow very rapid screening, since an individual cell containing the desired cDNA is uniquely marked on its surface by expression of the desired ligand. This rare cell can be individually detected within a background of millions of other cells and thus allows isolation of the ligand-encoding cDNA (most efficiently (CM) process that is formally identical to methods previously from each cell line was passed over a BIAcore sensor chip that had used to clone receptors using epitope-tagged ligands TIE2-Fc covalently coupled to it. Specificity of binding was assessed (Davis et al., 1991) . Here we introduce an extension of receptors but also for identifying interacting partners for Lysates of cells were immunoprecipitated (I.P.) with anti-TIE2 antithe plethora of uncharacterized secreted proteins being bodies and analyzed for levels of tyrosine-phosphorylated TIE2 receptor. discovered in the attempt to sequence the mammalian genome. Figure 1B ). Despite the detectable binding in Results their conditioned media, no binding of TIE2-Fc to the surface of either SHEP1-1 or C2C12ras cells could be Identification of a Source for a TIE2 Binding detected, indicating that both cell lines were producing and Phosphorylating Activity a secreted as opposed to a membrane-bound ligand To identify potential sources for TIE2 ligands, we confor TIE2. structed a probe molecule consisting of the ectodomain of TIE2 fused to the Fc portion of human IgG1 as well Secretion-Trap Expression Cloning as control fusion proteins in which the ectodomain of of a TIE2 Ligand TrkB or TIE1 replaced the TIE2 sequences (designated We have previously shown that receptor-Fc fusion pro-TIE2-Fc, TrkB-Fc, and TIE1-Fc, respectively). These teins can be effectively used for the expression cloning molecules were purified and coupled to the surface of of cDNAs encoding membrane-bound ligands, in partica BIAcore sensor chip (as per Stitt et al., 1995) , which ular by using them to surface-label rare ligand-bearing was then used to screen conditioned media from a varicells individually within a large population of libraryety of cell lines for binding activity that was specific transfected cells (Davis et al., 1994) ; after detection of for TIE2. Two cell lines, the human neuroepithelioma the rare cell expressing the desired ligand on its surface, cell line SHEP1-1 and the mouse myoblast cell line the cDNA encoding the ligand was rescued from the C2C12ras, were found to have binding activity that could labeled cell (Davis et al., 1994) . We devised an extension be competed by the addition of soluble TIE2-Fc but not of this method ( Figure 2A ) that would be applicable to TrkB-Fc ( Figure 1A ). In addition, conditioned media from secreted ligands, based on the notion that a secreted these cell lines could induce tyrosine phosphorylation ligand is, at least temporarily, trapped inside vesicular of the TIE2 receptor in endothelial cells ( Figure 1B ). The compartments of the cell until it is exocytosed. We reacomponent of the conditioned media that induced phossoned that if cells were appropriately fixed and permephorylation was presumably the same as the component abilized, it might be possible to detect the ligand en route that specifically bound TIE2-Fc because the phosphorylating activity could be depleted by beads coated with to secretion by using the receptor-Fc fusion protein as mouse Angiopoietin-1, respectively, since additional related ligands have also been isolated (P. F. J. et al., unpublished data). The DNA sequence of both the human and mouse Angiopoietin-1 cDNA clones were determined, revealing open reading frames encoding 498 amino acids and sharing 97.6% identity ( Figure 3A) . Additional cDNA clones were also derived by hybridization screening of a human fetal lung library and of a library of the human cell line T98G. The sequences of all of the human clones were identical, except that the clone derived from T98G carried a short three-base deletion, which led to the deletion of a single glycine residue at position 269 of the amino acid sequence. RNAse protection assays revealed that mRNAs carrying the three-base deletion were present as a minority population in all of the RNA samples examined that were positive for Angiopoietin-1 (data not shown). It is not known whether this deletion has functional significance. However, the sequence at the deletion point matches the consensus sequence of a splice junction after the completion of splicing, so it seems possible that the deletion is simply a consequence of some type of "exon slippage." of these proteins where they are known to possess coiled-coil quaternary structure. An analysis of the amino acid sequence, using algorithms developed to an immunohistochemical probe. This approach would estimate the probability of coiled-coil structure in a given allow the identification of rare cells expressing the ligand protein sequence, revealed a high probability of coiledwithin a large population of cells transfected with an coil structure in this region. The second region, conexpression library; plasmid DNA encoding the ligand sisting of residues 280-498, had strong similarity to a could then be directly rescued from these rare cells.
TIE2-Fc (
family of proteins, including fibrinogen, tenascin, hfrep, cDNA expression libraries were constructed from huficolin, and the Drosophila protein SCABROUS, that man SHEP1-1 and mouse C2C12ras cells, both of which share a region of homology about 200 amino acids long are sources of TIE2 ligand, and were screened according ( Figure 3C ). to the strategy outlined above. In each case, rare cells ‫1ف(‬ in 10 6 ) were identified when COS cells transfected with the libraries were stained with TIE2-Fc fusion proBiochemical Characterization of Angiopoietin-1 To examine the biochemical properties of Angiopoieteins. For each of these stained cells, plasmid DNA was rescued, electroporated into bacterial cells, and amplitin-1, we expressed it in COS cells and studied the conditioned media produced by the transfected cells. Westfied to produce an enriched pool of much lower complexity than the original library; each of these primary ern blot analysis revealed that Angiopoietin-1 was a 70 kDa protein, larger than would be predicted from its pools of plasmids was then used to retransfect COS cells. In contrast to the rare TIE2-Fc stained cells seen amino acid sequence ( Figure 4A ). Because the sequence contained several potential glycosylation sites, we exfollowing library transfections, cells transfected with the primary pools displayed many TIE2-Fc stained cells, as amined the effect of treatment with PNGase-F, which removes sugar residues. This treatment did indeed reshown in Figure 2B (each with the typical appearance of intra-Golgi staining, as would be expected for a protein duce the molecular weight to the expected ‫55ف‬ kDa, thus confirming that Angiopoietin-1 is a glycoprotein detected en route to secretion), demonstrating that considerable enrichment for plasmids encoding TIE2 li-( Figure 4A ). To determine whether recombinant Angiopoietin-1 gands had been achieved. Examination of individual plasmids derived from the primary pools revealed that could bind in secreted form to the TIE2 receptor, we examined conditioned media from COS cells transa high percentage were positive for TIE2-Fc staining following transfection into COS cells and therefore confected with Angiopoietin-1 cDNAs for binding activity on BIAcore sensor chips coupled to TIE2-Fc, TIE1-Fc, or tained cDNAs encoding either human (from SHEP1-1 cells) or mouse (from C2C12ras cells) versions of a liTrkB-Fc. Angiopoietin-1-containing conditioned media displayed binding activity only to the TIE2-Fc surface gand for TIE2. We designate these ligands human and ( Figure 4B ), and this binding could be competed only proliferative potency of several of these factors with the effects of Angiopoietin-1 on cultured endothelial cells. with the simultaneous addition of excess soluble TIE2-Fc but not TrkB-Fc or TIE1-Fc ( Figure 4B ), together demWhen human endothelial cells were treated with basic fibroblast growth factor, VEGF, or epidermal growth faconstrating that Angiopoietin-1 is specific for TIE2. The binding affinity was estimated at K D ϭ 3.7 nM based tor, proliferation was readily induced ( Figure 5A and data not shown). However, under the same culture condion an assay in which the ligand was immobilized on nitrocellulose and probed with varying amounts of TIE2-tions, concentrations of Angiopoietin-1 that are higher than necessary to induce robust tyrosine phosphorylaFc ( Figure 4C ).
To examine whether cloned Angiopoietin-1 could intion of TIE2 did not elicit a detectable growth response ( Figure 5B ). In another assay typically used to evaluate duce tyrosine phosphorylation of TIE2, we challenged bovine and human endothelial cells with COS cell condiangiogenic factors, in which factors such as basic fibroblast growth factor or VEGF induce endothelial cell tutioned media containing Angiopoietin-1. Angiopoietin-1 could induce tyrosine phosphorylation of TIE2 in all of bules to form within collagen matrices, chronic addition of Angiopoietin-1 was unable to induce tubule formation the endothelial cell lines examined (Figures 4D and 4E) , and this induction could be blocked by the addition of (data not shown). Because Angiopoietin-1 did not appear to display the excess soluble TIE2-Fc but not TrkB-Fc ( Figure 4D ). Thus, recombinant Angiopoietin-1 both binds and actibiologic activities typical of other endothelial cell growth factors, we decided to verify that other ways of activatvates TIE2.
ing the TIE2 catalytic domain also did not lead to proliferative responses. We thus constructed a chimeric recep-
Angiopoietin-1 Does Not Induce Growth Responses in Endothelial Cells
tor consisting of the ectodomain of TrkC fused to the cytoplasmic domain of TIE2, which thereby allowed actiFactors involved in angiogenesis often have proliferative effects on cultured endothelial cells. We compared the vation of the TIE2 kinase domain following NT3 addition FGF ( Figure 5C ). In contrast, when treated with NT3, the TrkC cells proliferated, whereas the TrkC/TIE2 cells did not ( Figure 5D ), even though tyrosine phosphorylation of the chimeric receptor was clearly induced in these cells by NT3 ( Figure 5D , inset). Taken together, our results indicate that Angiopoietin-1 activation of TIE2 does not induce the typical growth responses seen with other endothelial cell growth factors, suggesting that it may have actions that are not revealed by classic in vitro assays previously used to characterize endothelial growth factors. Consistent with this possibility, in an accompanying article (Suri et al., 1996) we report that disruption of the Angiopoietin-1 gene leads to distinctive defects in embryonic vascular development unlike those seen in embryos lacking VEGF (but similar to those in embryos lacking TIE2), suggesting that Angiopoietin-1 plays a unique collaborative and sequential role with VEGF.
Localization of Angiopoietin-1 in Developing Embryos
To obtain insight into the possible role of Angiopoietin-1 during vascular development, its expression in developing embryos was examined by in situ hybridization. To compare the distribution of Angiopoietin-1 with the distribution of endothelial cells, the in situ hybridization analysis was performed on parallel sections with an endothelial-specific probe. (Although both TIE1 and TIE2 suggest that it plays a particularly important role in the heart early in development and an increasingly wide-( Figure 5D , inset). We transfected this chimeric receptor spread role as the rest of the vasculature matures. into MG87 fibroblasts, which display proliferative or survival responses following activation of many introduced receptor tyrosine kinases (e.g., Glass et al., 1991) 1994). This method provided considerable simplification responsible for assembling the fibrinogen-like domain into some type of multimeric structure. Preliminary reover iterative panning methods or techniques based on sults (data not shown) indicate that this possibility is construction of pooled libraries, which entails screening indeed the case. It will be relevant to determine the of individual pools followed by subdivision and reprecise structure of Angiopoietin-1, to identify the porscreening of positive pools. Here we have extended tions of it that are required for binding to TIE2, and to the single-cell method to include secreted ligands, in determine whether multimeric structure is necessary for a method we have termed secretion-trap expression binding or activation. Because some proteins with cloning, thus providing an alternative route to the more coiled-coil structure are found as heteromultimers of time-consuming traditional approaches to this difficult similar proteins rather than as homomultimers (e.g., fiproblem. We describe application of secretion-trap exbrinogen [Doolittle, 1984] ), the possibility exists that Anpression cloning for the cloning of a novel secreted giopoietin-1 can also form heteromeric structures with ligand for the TIE2 receptor. We anticipate that this other, closely related proteins; indeed, several such relamethod may be useful not only for the cloning of setives of Angiopoietin-1 have been identified (P. F. J. et creted ligands for other orphan receptors but also for al., unpublished data). Different combinations of Angiothe identification of interacting partners for the many poietin-1-related molecules may have different receptor secreted proteins of unknown function currently being specificities. discovered in large sequencing projects.
In contrast to previously characterized angiogenic The structure of Angiopoietin-1 is unlike that of any factors such as VEGF and FGF, Angiopoietin-1 is, under other angiogenic factor or any other factors that bind the conditions tested here, unable to elicit some of the to receptor tyrosine kinases. Numerous proteins are responses that are typical of angiogenic factors. Apparknown to possess domains resembling the C-terminal ently, Angiopoietin-1 serves some function other than domain of fibrinogen, but in most cases little is known proliferation or tubule formation in endothelial cells. Beabout the functions of these proteins. It is noteworthy cause vascular development evidently is a complex, that all known examples of this type of protein have the multistep process that requires appropriate formation fibrinogen-like domain at the C-terminus and that most and integration of the vasculature into its surrounding are accompanied by N-terminal domains that have tissue, it would not be surprising that some factors might coiled-coil structure (one exception is the ficolins, which regulate aspects of endothelial maturation that occur have collagen-like N-terminal regions); it is not known after the initial stages of proliferation and tubule formawhether these shared structures form the basis for some tion. The expression of Angiopoietin-1 in the immediate common functional theme. However, it is known that vicinity of developing blood vessels implicates this licoiled-coil regions typically are involved in the assembly gand in processes that are important for vascularization. of the protein into multimeric structures; of note, the The later expression of TIE2 as compared to that of the collagen-like N-terminal region of ficolin is also thought VEGF receptors (Dumont et al., 1995) , together with our to be involved in multimerization. It seems reasonable findings that Angiopoietin-1 expression seems to become more widespread as development proceeds, is that the coiled-coil domain of Angiopoietin-1 may be (e.g., Kaipainen et al., 1994) , Angiopoietin-1 may provide a means for specifically targeting tumor vasculature, for example by conjugating it to a cytotoxin, as has been suggested for VEGF (Burrows and Thorpe, 1994 ). In contrast to clinical situations in which attacking neovascularizing endothelia might be desirable, there are situations in which it would be useful to promote angiogenic processes, such as to induce collateral vascularization in an ischemic heart or limb (Ferrara et al., 1995) . Precise understanding of the biologic roles of Angiopoietin-1 and its relatives and of how they may collaborate with members of the VEGF family may lead to novel and therapeutically significant strategies for promoting or inhibiting neovascularization.
Experimental Procedures
Cell Culture and Production of Conditioned Media SHEP1-1 cells were obtained from ATCC. C2C12ras cells were derived from C2C12 cells by stable transfection with an expression plasmid containing the ras oncogene. Cells were grown in defined medium without added serum, and conditioned media were harvested and clarified by centrifugation. These media were brought to 1 mM phenylmethylsulfonyl fluoride and 0.14 U/ml aprotinin, concentrated approximately 10-fold with 3000 MWCO membranes (Amicon), and stored at Ϫ80ЊC, as previously described (Stitt et al., 1995) .
Production and Purification of Receptor-Fc Fusion Proteins
The ectodomains of each of TIE2, TIE1, and TrkB were fused to the hinge, C H 2, and C H 3 regions of human IgG1 via a bridging sequence Figure 6 . In Situ Analysis of Angiopoietin-1 Gene Expression in De-(glycine-proline-glycine) as previously described (Davis et al., 1994) . veloping Embryos
The fusion proteins were produced according to standard protocols in Sf-21AE cells infected with baculovirus vectors bearing the re-(A, C, E, and G) were probed with TIE1 to localize endothelial cells. spective fusion constructs (O'Reilly et al., 1992) . Recombinant fusion (TIE2 in situ analyses, of inferior quality and thus not shown, revealed proteins were then purified by protein A-Sepharose (Pharmacia) similar staining patterns.) (B, D, F, and H) were probed with Angiochromatography. poietin-1. (A and B) Saggital cross section of rat embryos showing general correlation between endothelial cells and Angiopoietin-1 expression BIAcore Analysis in surrounding mesenchyme.
Binding activity measured by use of BIAcore biosensor technology (C and D) Enlargement of lower left insets in (A) and (B), highlighting (Pharmacia Biosensor) was performed essentially as previously deexpression of Angiopoietin-1 in the vicinity of the intersegmental scribed (Stitt et al., 1995) ; specific binding to the TIE2 surface was vessels.
determined by incubating the samples with 25 g/ml of TIE2-Fc, (E and F) Enlargement of upper right insets in (A) and (B), highlighting TIE1-Fc, or TrkB-Fc prior to assay. expression of Angiopoietin-1 in mesenchyme surrounding several vessels (asterisks) in the peritoneum. Expression Cloning (G and H) Expression of Angiopoietin-1 in the developing eye, adjacDNA libraries of SHEP1-1 and C2C12ras cells were constructed cent to developing vasculature.
in the expression vector pJFE14 as described (Davis et al., 1994) . COS-7 cells were transfected with the libraries (1 g/100 mm dish). Two days after transfection, cells were washed with PBS and then consistent with the notion that Angiopoietin-1 plays an fixed with PBS/1.8% formaldehyde for 15 min. Cells were then perangiogenic role later and distinct from that of VEGF.
meabilized and blocked with assay buffer (PBS/10% calf serum)
Indeed, the findings of our accompanying study (Suri et containing 0.1% Triton X-100 for 15 min. Cells were then treated al. , 1996) , in which embryos lacking Angiopoietin-1 were with assay buffer containing 1 g/ml TIE2-Fc for 30 min. After two analyzed for their vascular defects, are consistent with PBS washes, cells were incubated with assay buffer containing alkaline phosphatase-conjugated goat anti-human antibodies for this notion. The availability of a recombinant ligand for cells and then assayed as described above for the presence of TIE2-In Situ Analysis Fresh-frozen E13.5 rat embryos were sectioned by cryostat and Fc-staining cells.
probed with
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S-labeled cRNAs as described (Valenzuela et al., 1993) . Probes were, for TIE1, a 1.3 kb fragment of rat TIE1 spanning Biochemical Analysis the last 309 codons and 375 bp of 3Ј untranslated sequence, and To identify Angiopoietin-1 on Western blots, antisera were raised for Angiopoietin-1, a 770 bp fragment of rat Angiopoietin-1 spanning against a synthetic peptide (NQRRNPENGGRRYNRIQHGQ) derived the last 253 codons and 12 bp of 3Ј untranslated sequence. Sections from the N-terminal region of Angiopoietin-1. These antisera were were immersed in radiographic emulsion (NTB-2, Kodak) and exaffinity purified with the same peptide. Supernatants from COS cells posed for 5-10 days. transfected with Angiopoietin-1 were treated with PNGase-F (New England Biolabs) according to the manufacturer's instructions and Acknowledgments acetone precipitated. Samples were electrophoresed on a polyacrylamide gel, transferred to an Immobilon membrane, and probed
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Murphy and E. Hubel for excellent graphics work. on nitrocellulose strips ‫002ف(‬ ng per dot). After blocking with PBS containing 10% calf serum, the strips were incubated for 1 hr with Received October 10, 1996; revised October 30, 1996. varying amounts of TIE2-Fc in PBS containing 2.5% calf serum and 0.1% Tween 20, followed by 2 ϫ 10 min washes in PBS containing References 0.1% Tween. Strips were then incubated for 1 hr in a goat antihuman 125 I-labeled second antibody (New England Biolabs, 1:250 Batard, P., Sansilvestri, P., Scheinecker, C., Knapp, W., Deblie, N., dilution) in the same buffer, followed by 3 ϫ 5 min washes, after Vainchenker, W., Buhring, H.J., Monier, M.N., Kukk, E., Partanen, which bound radioactivity was determined. For each concentration J., Matikainen, M.T., Alitalo, R., Hatzfield, J., and Alitalo, K. (1996 . (1996) . Abnormal blood vessel development and lethality maintained according to the supplier's instructions (Clonetics, Inc.).
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two-hybrid system: a method to identify and clone genes for proteins TIE2 receptor activation assays were done with late-confluency T-75 that interact with a protein of interest. Proc. Natl. Acad. Sci. USA flasks of endothelial cells that were serum starved in high glucose-88, 9578-9582. DMEM for 2-4 hrs. Conditioned media were placed on cells for Davis, S., Aldrich, T.H., Valenzuela, D.M., Wong, V., Furth, M.E., 5-10 minutes at 37ЊC. Cell lysis, TIE2 immunoprecipitations, and Squinto, S.P., and Yancopoulos, G.D. (1991) . The receptor for ciliary phosphotyrosine immunoblotting were performed largely as deneurotrophic factor. Science 253, 59-63. scribed (Stitt et al., 1995) , except that TIE2 immunoprecipitations Davis, S., Gale, N.W., Aldrich, T.H., Maisonpierre, P.C., Lhotak, V., were performed using a rabbit antiserum made to the conserved Pawson, T., Goldfarb, M., and Yancopoulos, G.D. (1994) . Ligands last 16 amino acids of mammalian TIE2 (RG133). To deplete C2C12
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